ライフサイエンスコーパス: the discretion of

1 rd, additional sensitive screening procedures were added at the discretion of the retinal physician: high-resolution spec

2 ncil for Graduate Medical Education but are administered at the discretion of individual institutions and are not standar

3 Concurrent therapies were administered at the discretion of the treating physician.

4 ductions in dose and frequency of administration allowed at the discretion of the treating physician.

5 ients) were taken off treatment after a prolonged CR and at the discretion of the treating clinician.

6 d other conditions, with the use of coronary angiography at the discretion of the operator.

7 The implant angle was chosen at the discretion of the physician performing TAVR.

8 eceive CP-751,871 in combination with oral dexamethasone at the discretion of the investigator.

9 chronic granulomatous disease were assessed and enrolled at the discretion of individual centres.

10 nd treatment period were offered open-label enzalutamide at the discretion of the patient and study investigator.

11 and any additional follow-up PET/CT scans will be funded at the discretion of the local Medicare administrator.

12 ntrol group, in which standard practices are implemented at the discretion of the attending physician, lack the ability t

13 w nasal cannula or mechanical ventilation was initiated, at the discretion of the attending physician.

14 Treatment is at the discretion of the local physician.

15 a year of age in a facility with a general anesthetic is at the discretion of the ophthalmologist.

16 ts with responsive or stable disease, but further use is at the discretion of the treating physician.

17 etastatic renal-cell carcinoma; a decision that was made at the discretion of the treating physician and patient.

18 r to receive usual care consisting of symptom monitoring at the discretion of clinicians.

19 Interventions were OPCAB or CABG/CPB, performed at the discretion of 14 faculty surgeons.

20 of measuring left ventricular function usually performed at the discretion of the invasive cardiologist during cardiac ca

21 ion, hemiportocaval shunt, or splenectomy) was performed at the discretion of the operating surgeon.

22 Coronary angiography was performed at the discretion of the physician.

23 The characteristics of angiograms performed at the discretion of the treating physician were reviewed.

24 PPIs were prescribed at the discretion of treating physicians; patients were followed

25 onal follow-up (18)F-FDG PET/CT scans will be reimbursed at the discretion of a local Medicare administrator, if deemed m

26 age >/= 18 years were prescribed peginterferon/ribavirin at the discretion of the treating physician according to country

27 o immediate surgery (lesioning or deep brain stimulation at the discretion of the local clinician) and best medical thera

28 s, every 6 months during years 4 and 5, and subsequently at the discretion of the physician; and carcinoembryonic antigen

29 herapy regimen (with the option to cross over to surgery at the discretion of the patient and surgeon).

30 study period, the use of the pediatric Isolator system, at the discretion of the treating physician, only rarely provide

31 e and stat laboratory hemoglobin measurements were taken at the discretion of the clinicians, who were blinded to noninva

32 n in immunosuppression and preemptive antiviral therapy, at the discretion of the attending team.

33 eolar radioactive colloid injection techniques were used at the discretion of each institution.

34 Secondary prophylaxis was used at the discretion of each treating clinician, without an institu

35 nents (e.g., hemodynamic measurements, ventriculography) at the discretion of the operator.

36 After the trial, treatment was at the discretion of the clinician.

37 Treatment after 6 months was at the discretion of the investigator.

38 Subsequent management, including additional imaging, was at the discretion of the physician.

39 o treat patients with stress doses of hydrocortisone was at the discretion of the treating intensivist and transplant sur

40 Use of preinjection and postinjection antibiotics was at the discretion of the treating ophthalmologist.

41 Systemic therapy was at the discretion of the treating physician.

42 All other care was at the discretion of the treating physician.

43 wash could be continued for up to eight additional weeks at the discretion of the clinician and patient.

44 ing of insertion and subsequent clinical management were at the discretion of the treating clinician.

45 r pre-enrollment FIGO clinical stage classification were at the discretion of the treating physician; overall frequency o

46 Postoperative therapies were at the discretion of the treating physicians.

47 racemic leucovorin 200 mg/m(2) or 400 mg/m(2), according to the discretion of the treating investigator, oxaliplatin 85 m

48 Use of MRAs was encouraged but left to the discretion of study investigators.

49 factors (eg, prothrombin complex concentrate), were left to the discretion of the treating physicians.

50 inded to clinicians and local clinical measurements left to the discretion of the treating providers.